Patents by Inventor Angkana Charoenyingwattana

Angkana Charoenyingwattana has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Risk assessment for cutaneous adverse drug reactions from antiretroviral agent
    Patent number: 9557341
    Abstract: The present invention provides a method of predicting the risk of a patient for developing cutaneous adverse drug reaction to non-nucleoside reverse transcriptase inhibitors such as nevirapine by using HLA-B*3505 allele and/or polymorphisms in the CCHCR1 gene.
    Type: Grant
    Filed: December 11, 2009
    Date of Patent: January 31, 2017
    Assignees: MAHIDOL UNIVERSITY, RIKEN, DEPARTMENT OF MEDICAL SCIENCES, MINISTRY OF PUBLIC, THAILAND CENTER OF EXCELLENCE FOR LIFE SCIENCES (OKMD)
    Inventors: Somnuek Sungkanuparph, Sasisopin Kiertiburanakul, Thanyachai Sura, Wasun Chantratita, Soranun Chantarangsu, Angkana Charoenyingwattana, Surakameth Mahasirimongkol, Michiaki Kubo, Taisei Mushiroda, Yusuke Nakamura
  • RISK ASSESSMENT FOR CUTANEOUS ADVERSE DRUG REACTIONS FROM ANTIRETROVIRAL AGENT
    Publication number: 20110301043
    Abstract: The present invention provides a method of predicting the risk of a patient for developing cutaneous adverse drug reaction to non-nucleoside reverse transcriptase inhibitors such as nevirapine by using HLA-B*3505 allele and/or polymorphisms in the CCHCR1 gene.
    Type: Application
    Filed: December 11, 2009
    Publication date: December 8, 2011
    Applicants: MAHIDOL UNIVERSITY, RIKEN, DEPARTMENT OF MEDICAL SCIENCES
    Inventors: Somnuek Sungkanuparph, Sasisopin Kiertiburanakul, Thanyachai Sura, Wasun Chantratita, Soranun Chantarangsu, Angkana Charoenyingwattana, Surakameth Mahasirimongkol, Michiaki Kubo, Taisei Mushiroda, Yusuke Nakamura